TRANSCRIPT APRF

PURPOSE:To obtain the new substance, being an acute phase response factor (APRF) of transcript of mammal, useful for supplying and suppressing APRF cytokinin function and suitable for treating inflammatory diseases in which cytokinin participates as APRF function inhibitor. CONSTITUTION:This new pol...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SHINRIYOU SHIZUO, KISHIMOTO CHUZO
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA DERIVATIVES THEREOF ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS SUGARS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PURPOSE:To obtain the new substance, being an acute phase response factor (APRF) of transcript of mammal, useful for supplying and suppressing APRF cytokinin function and suitable for treating inflammatory diseases in which cytokinin participates as APRF function inhibitor. CONSTITUTION:This new polypeptide is an acute phase response factor(APRF) having an amino acid sequence containing an amino acid sequence expressed by the formula and being a transcript of mammal and is participated in intracellular signal transfer of interleukin 6 (IL-6), useful for complementing or suppressing APRF function, capable of utilizing in searching a substance inhibiting the function of APRF and effective in treating various diseases in which cytokinin such as IL-6 are participated, e.g., inflammatory diseases, leukemia, cancer, bone breakage, pulmonary hypertension, etc., as an active ingredient for APRF function inhibitor. Furthermore, its homologue and fragment are provided. The compound is obtained by integrating cDNA isolated from liver or placental cDNA library of mammal into an expression vector and expressing the vector with a host.